Multaq Recall News
Multaq Recall: A patient who completes therapy, waits six months, and remains virologically negative is described as having a sustained virologic response (SVR), and the treatment is considered a success. For patients who achieve an SVR, a relapse is highly unlikely. This is essentially the same as a cure for 97 to 99 percent of [...]